Nasal Continuous Positive Airway Pressure and High-Flow Nasal Cannula Today

Area of Science:

• Neonatology
• Pediatric Respiratory Medicine
• Critical Care

Background:

• Respiratory distress syndrome (RDS) is a common condition in preterm infants.
• Noninvasive respiratory support is crucial for managing RDS and preventing mechanical ventilation.
• Nasal continuous positive airway pressure (nCPAP) and high-flow nasal cannula (HFNC) are primary noninvasive support methods.

Purpose of the Study:

• To review the mechanisms and effects of nCPAP and HFNC in preterm infants with RDS.
• To compare the effectiveness of nCPAP and HFNC in preventing mechanical ventilation.
• To discuss device characteristics, failure risks, and adverse effects of these support methods.

Main Methods:

• Literature review of studies on nCPAP and HFNC in preterm infants with RDS.
• Analysis of clinical evidence regarding the use of nCPAP and HFNC as primary support or post-extubation.
• Evaluation of device interfaces, failure rates, and adverse events associated with nCPAP and HFNC.

Main Results:

• nCPAP is generally preferred as the initial noninvasive respiratory support for preterm infants with RDS.
• HFNC demonstrates effectiveness as an alternative to nCPAP following extubation.
• Both nCPAP and HFNC have specific device characteristics, potential failure risks, and adverse effects that require consideration.

Conclusions:

• nCPAP is the preferred initial noninvasive respiratory support for preterm infants with RDS.
• HFNC serves as an effective alternative to nCPAP for respiratory support after extubation in the neonatal intensive care unit.
• Careful consideration of device selection, patient interface, and potential adverse effects is essential for optimizing noninvasive respiratory support in preterm infants.